Carcinoma, Large Cell - 21 Studies Found

Completed : RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
:
  • Carcinoma, Large Cell
  • Neuroendocrine Tumors

: 2011-03-16
:
  • Drug: RAD001 Participants star
Recruiting : Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix
: Cervical Cancer
: 2012-05-23
: Behavioral: Questionnaires Completion of online surveys taking approximately 15 - 20 minutes.
Recruiting : A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment
:
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Squamous
  • : 2011-12-14
    :
    • Drug: Docetaxel Docetaxel (dil
Terminated : Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)
:
  • Carcinoma, Non-Small-Cell Lung
  • Adenocarcinoma
  • : 2008-02-29
    : Drug: Temozolomide 5-mg, 20-mg, and 100-mg gel capsules, 75 mg/m^2 PO daily for 21 consecutive days, fol
Terminated : -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer
:
  • Carcinoma, Non-Small Cell Lung
  • Adenocarcinoma
  • Carcinoma, S
    : 2011-09-24
    :
    • Drug: PF-02341066/PF-00299804

Active, not recruiting : Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
:
  • Non-Small Cell Lung Cancer
  • Carcinoma
  • Squamous Cell Carcino
    : 2014-05-28
    :
    • Drug: nab-paclitaxel Other Nam
Completed : Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
:
  • Non-small Cell Carcinoma
  • Adenocarcinoma of Lung
  • Squamous C
    : 2003-11-19
    : Biological: Drug: Hyperacute Lung Cancer Cell Vaccine At dose levels I IV the vaccine cells will be inje
Recruiting : A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
:
  • Non-Small Cell Lung Cancer
  • NSCLC
  • Adenocarcinoma
  • : 2015-02-12
    :
    • Drug: MM-121 Investigational,

Recruiting : PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
:
  • Neuroendocrine Tumors
  • Carcinoma, Small Cell Lung
  • : 2016-10-13
    : Drug: PEN-221 Administration of PEN-221 once every three weeks
Completed : A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
: Non Small Cell Lung Cancer
: 2011-05-26
:
  • Drug: IPI 504 plus Docetaxel

Next >>>